Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein Degraders

Key Points

The aim is to explore the effectiveness of heterobifunctional protein degraders targeting ALK2.
Development of compounds with improved degradation potency for ALK2.
Evaluation of the utility of these compounds in studying ALK2's role in disease.
Identified compounds enhance the degradation of ALK2.
Demonstrated potential applications in drug discovery for human diseases.

This research demonstrates targeting ALK2 improves degradation in human disease, suggesting novel avenues for drug discovery.

No takes yet. Share an insight, caveat, or question.

Webb et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share